Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an
 HIV
 ‐Positive Patient: A Case Report

Matteo Bellia; RICCARDO MOIA; Mattia Schipani; Carola Sella; Mariangela Greco; Wael Al Essa; Abdurraouf Mokhtar Mahmoud; Gianluca GAIDANO; Andrea Patriarca

doi:10.1002/ccr3.70577

Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report

Matteo Bellia
, RICCARDO MOIA
, Mattia Schipani
, Carola Sella
, Mariangela Greco
, Wael Al Essa
, Abdurraouf Mokhtar Mahmoud
, Gianluca GAIDANO
, Andrea Patriarca

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

: Managing immune thrombocytopenia (ITP) in HIV patients remains challenging due to refractory cases and treatment limitations. This report highlights fostamatinib as a safe, effective, and antiretroviral therapy-compatible option, offering durable platelet stabilization in a difficult-to-treat population.

Lingua originale	Inglese
Rivista	Clinical Case Reports
Volume	13
Numero di pubblicazione	7
DOI	https://doi.org/10.1002/ccr3.70577
Stato di pubblicazione	Pubblicato - 2025

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

ART
HIV infection
fostamatinib
immune thrombocytopenia

Accesso al documento

10.1002/ccr3.70577

https://hdl.handle.net/11579/221671

Altri file e collegamenti

handle

Cita questo

@article{483f44e772ff49f2b921104444cfb581,

title = "Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report",

abstract = ": Managing immune thrombocytopenia (ITP) in HIV patients remains challenging due to refractory cases and treatment limitations. This report highlights fostamatinib as a safe, effective, and antiretroviral therapy-compatible option, offering durable platelet stabilization in a difficult-to-treat population.",

keywords = "ART, HIV infection, fostamatinib, immune thrombocytopenia, ART, HIV infection, fostamatinib, immune thrombocytopenia",

author = "Matteo Bellia and RICCARDO MOIA and Mattia Schipani and Carola Sella and Mariangela Greco and \{Al Essa\}, Wael and Mahmoud, \{Abdurraouf Mokhtar\} and Gianluca GAIDANO and Andrea Patriarca",

year = "2025",

doi = "10.1002/ccr3.70577",

language = "English",

volume = "13",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "7",

}

TY - JOUR

T1 - Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report

AU - Bellia, Matteo

AU - MOIA, RICCARDO

AU - Schipani, Mattia

AU - Sella, Carola

AU - Greco, Mariangela

AU - Al Essa, Wael

AU - Mahmoud, Abdurraouf Mokhtar

AU - GAIDANO, Gianluca

AU - Patriarca, Andrea

PY - 2025

Y1 - 2025

N2 - : Managing immune thrombocytopenia (ITP) in HIV patients remains challenging due to refractory cases and treatment limitations. This report highlights fostamatinib as a safe, effective, and antiretroviral therapy-compatible option, offering durable platelet stabilization in a difficult-to-treat population.

AB - : Managing immune thrombocytopenia (ITP) in HIV patients remains challenging due to refractory cases and treatment limitations. This report highlights fostamatinib as a safe, effective, and antiretroviral therapy-compatible option, offering durable platelet stabilization in a difficult-to-treat population.

KW - ART

KW - HIV infection

KW - fostamatinib

KW - immune thrombocytopenia

KW - ART

KW - HIV infection

KW - fostamatinib

KW - immune thrombocytopenia

UR - https://iris.uniupo.it/handle/11579/221671

U2 - 10.1002/ccr3.70577

DO - 10.1002/ccr3.70577

M3 - Article

SN - 2050-0904

VL - 13

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 7

ER -